Review Article

Copper excess, zinc deficiency, and cognition loss in Alzheimer's disease

George J. Brewer

Corresponding Author

E-mail address:brewergj@umich.edu

Department of Human Genetics, Medical School University of Michigan, Ann Arbor, MI, USA

Adeona Pharmaceuticals, Ann Arbor, MI, USA

Tel.: 734‐395‐1070; Fax: 734‐332‐7878
Department of Human Genetics, Medical School University of Michigan, Ann Arbor 48103, MI, USA
Search for more papers by this author
First published: 22 March 2012
Cited by: 69

Abstract

In this special issue about biofactors causing cognitive impairment, we present evidence for and discuss two such biofactors. One is excess copper, causing neuronal toxicity. The other is zinc deficiency, causing neuronal damage. We present evidence that Alzheimer's disease (AD) has become an epidemic in developed, but not undeveloped, countries and that the epidemic is a new disease phenomenon, beginning in the early 1900s and exploding in the last 50 years. This leads to the conclusion that something in the developed environment is a major risk factor for AD. We hypothesize that the factor is inorganic copper, leached from the copper plumbing, the use of which coincides with the AD epidemic. We present a web of evidence supporting this hypothesis. Regarding zinc, we have shown that patients with AD are zinc deficient when compared with age‐matched controls. Zinc has critical functions in the brain, and lack of zinc can cause neuronal death. A nonblinded study about 20 years ago showed considerable improvement in AD with zinc therapy, and a mouse AD model study also showed significant cognitive benefit from zinc supplementation. In a small blinded study we carried out, post hoc analysis revealed that 6 months of zinc therapy resulted in significant benefit relative to placebo controls in two cognitive measuring systems. These two factors may be linked in that zinc therapy significantly reduced free copper levels. Thus, zinc may act by lowering copper toxicity or by direct benefit on neuronal health, or both.

Number of times cited: 69

  • , Role of Copper in the Onset of Alzheimer’s Disease Compared to Other Metals, Frontiers in Aging Neuroscience, 9, (2018).
  • , A novel copper selective sensor based on ion imprinted 2-vinylpyridine polymer, Canadian Journal of Chemistry, 10.1139/cjc-2018-0178, 96, 12, (1027-1036), (2018).
  • , Copper and Zinc Dysregulation in Alzheimer’s Disease, Trends in Pharmacological Sciences, 10.1016/j.tips.2018.10.001, (2018).
  • , Amyloidogenesis induced by diet cholesterol and copper in a model mouse for Alzheimer’s disease and protection effects of zinc and fluvastatin, Brain Research Bulletin, 10.1016/j.brainresbull.2018.09.003, 143, (1-8), (2018).
  • , Sol–gel synthesis, physicochemical characterization, and analytical applications of copper selective composite cation exchanger: Polyvinyl alcohol Ce(IV) phosphate, Polymer Composites, 38, 2, (332-340), (2015).
  • , Metal ions influx is a double edged sword for the pathogenesis of Alzheimer’s disease, Ageing Research Reviews, 10.1016/j.arr.2016.10.003, 35, (265-290), (2017).
  • , Non-Ceruloplasmin Copper Distincts Subtypes in Alzheimer’s Disease: a Genetic Study of ATP7B Frequency, Molecular Neurobiology, 54, 1, (671), (2017).
  • , Summaries of the Micronutrient Symposium of the 2016 Meeting of the American College of Nutrition, Journal of the American College of Nutrition, 36, 4, (310), (2017).
  • , Mineral status and superoxide dismutase enzyme activity in Alzheimer’s disease, Journal of Trace Elements in Medicine and Biology, 44, (83), (2017).
  • , Copper in Wilson’s and Alzheimer’s Diseases, Copper-Lowering Therapy in Cancer and Other Diseases, and Copper Deficiency, Molecular, Genetic, and Nutritional Aspects of Major and Trace Minerals, 10.1016/B978-0-12-802168-2.00010-5, (115-129), (2017).
  • , Serum Copper, Zinc, and Iron Levels in Patients with Alzheimer's Disease: A Meta-Analysis of Case-Control Studies, Frontiers in Aging Neuroscience, 9, (2017).
  • , Commentary: The Case for Abandoning Therapeutic Chelation of Copper Ions in Alzheimer’s Disease, Frontiers in Neurology, 8, (2017).
  • , Copper-2 Hypothesis for Causation of the Current Alzheimer’s Disease Epidemic Together with Dietary Changes That Enhance the Epidemic, Chemical Research in Toxicology, 30, 3, (763), (2017).
  • , Cross talk between neurometals and amyloidogenic proteins at the synapse and the pathogenesis of neurodegenerative diseases, Metallomics, 9, 6, (619), (2017).
  • , Metabolic relationship between diabetes and Alzheimer's Disease affected by Cyclo(His-Pro) plus zinc treatment, BBA Clinical, 10.1016/j.bbacli.2016.09.003, 7, (41-54), (2017).
  • , Alzheimer’s disease: How metal ions define β-amyloid function, Coordination Chemistry Reviews, 10.1016/j.ccr.2017.05.007, 351, (127-159), (2017).
  • , Complémentation ou supplémentation en oligo-éléments : qui, pourquoi, comment ?, Nutrition Clinique et Métabolisme, 31, 2, (93), (2017).
  • , The Petrography, Mineralogy and Geochemistry of Some Cu- and Pb-Enriched Coals from Jungar Coalfield, Northwestern China, Minerals, 8, 1, (5), (2017).
  • , Zinc in Autism, Biometals in Neurodegenerative Diseases, 10.1016/B978-0-12-804562-6.00009-9, (153-173), (2017).
  • , A switch‐off fluorescence probe towards Pb(II) and cu(II) ions based on a calix[4]pyrrole bearing amino‐quinoline group, Luminescence, 32, 8, (1398-1404), (2017).
  • , Purine‐Based Fluorescent Sensors for Imaging Zinc Ions in HeLa Cells, European Journal of Inorganic Chemistry, 2017, 36, (4202-4209), (2017).
  • , Dietary copper restriction in Wilson’s disease, European Journal of Clinical Nutrition, (2017).
  • , Portable and sensitive detection of copper(II) ion based on personal glucose meters and a ligation DNAzyme releasing strategy, Sensors and Actuators B: Chemical, 240, (1091), (2017).
  • , Novel europium (III)-gatifloxacin complex structure with dual functionality for pH sensing and metal recognition in aqueous environment, Optical Materials, 10.1016/j.optmat.2016.06.051, 60, (1-5), (2016).
  • , Aberrance of Serum Zinc and Free Copper Level in Wilson Disease, Journal of Pediatric Gastroenterology and Nutrition, 62, 5, (e46), (2016).
  • , The effect of copper from water and food: changes of serum nonceruloplasmin copper and brain's amyloid-beta in mice, Food & Function, 7, 9, (3740), (2016).
  • , A single chemosensor for bimetal Cu( ii ) and Zn( ii ) in aqueous medium , RSC Advances, 10.1039/C6RA01030J, 6, 40, (33798-33803), (2016).
  • , A novel fluorescence enhanced route to detect copper(II) by click chemistry-catalyzed connection of Au@SiO 2 and carbon dots, Sensors and Actuators B: Chemical, 233, (426), (2016).
  • , Isoflurane anesthesia exacerbates learning and memory impairment in zinc-deficient APP/PS1 transgenic mice, Neuropharmacology, 111, (119), (2016).
  • , Molecular dynamic studies of amyloid-beta interactions with curcumin and Cu2+ ions, Chemical Papers, 10.1515/chempap-2015-0134, 69, 9, (2015).
  • , Zinc in Alzheimer’s Disease: A Meta-Analysis of Serum, Plasma, and Cerebrospinal Fluid Studies, Journal of Alzheimer's Disease, 46, 1, (75), (2015).
  • , Europium( iii ) β-diketone complex as portable luminescent chemosensor for naked eye Cu 2+ detection and recyclable on–off–on vapor response , RSC Advances, 10.1039/C5RA19710D, 5, 124, (102535-102541), (2015).
  • , Efficacy of Zinc Sulfate as an Add-on Therapy to Risperidone versus Risperidone Alone in Patients With Schizophrenia: A Double-Blind Randomized Placebo-Controlled Trial, Iranian Journal of Psychiatry and Behavioral Sciences, 9, 1, (2015).
  • , Efficacy of Zinc Sulfate as an Add-on Therapy to Risperidone Versus Risperidone Alone in Patients With Schizophrenia: A Double-Blind Randomized Placebo-Controlled Trial, Iranian Journal of Psychiatry and Behavioral Sciences, 9, 3, (2015).
  • , Serum Copper Level Significantly Influences Platelet Count, Lymphocyte Count and Mean Cell Hemoglobin in Sickle Cell Anemia, Zahedan Journal of Research in Medical Sciences, In Press, In Press, (2015).
  • , The Role of Copper in Human Diet and Risk of Dementia, Current Nutrition Reports, 4, 2, (114), (2015).
  • , Copper-2 Ingestion, Plus Increased Meat Eating Leading to Increased Copper Absorption, Are Major Factors Behind the Current Epidemic of Alzheimer’s Disease, Nutrients, 7, 12, (10053), (2015).
  • , A Human-Based Integrated Framework forAlzheimer’s Disease Research, Journal of Alzheimer's Disease, 47, 4, (857), (2015).
  • , Divalent Copper as a Major Triggering Agent in Alzheimer’s Disease, Journal of Alzheimer's Disease, 46, 3, (593), (2015).
  • , Distinct effects of Cu 2+ -binding on oligomerization of human and rabbit prion proteins , Acta Biochimica et Biophysica Sinica, 10.1093/abbs/gmv081, 47, 10, (842-850), (2015).
  • , Adsorption of Cu(II) onto three types of engineering materials in the presence of S,S-EDDS chelate: equilibrium, kinetics, and thermodynamics, Desalination and Water Treatment, 56, 9, (2502), (2015).
  • , Silica nanoparticles doped with a europium(III) complex and coated with an ion imprinted polymer for rapid determination of copper(II), Microchimica Acta, 182, 3-4, (753), (2015).
  • , Positron emission tomography for measurement of copper fluxes in live organisms, Annals of the New York Academy of Sciences, 1314, 1, (24-31), (2014).
  • , Value of serum nonceruloplasmin copper for prediction of mild cognitive impairment conversion to Alzheimer disease, Annals of Neurology, 75, 4, (574-580), (2014).
  • , Studying variability in human brain aging in a population-based German cohort—rationale and design of 1000BRAINS, Frontiers in Aging Neuroscience, 6, (2014).
  • , Treatment of Wilson’s disease: our patients deserve better, Expert Opinion on Orphan Drugs, 2, 12, (1245), (2014).
  • , Resveratrol and Alzheimer’s disease: message in a bottle on red wine and cognition, Frontiers in Aging Neuroscience, 6, (2014).
  • , Colorimetric Detection of Copper(II) Ion Using Click Chemistry and Hemin/G-Quadruplex Horseradish Peroxidase-Mimicking DNAzyme, Analytical Chemistry, 10.1021/ac501739a, 86, 13, (6387-6392), (2014).
  • , Biological consequences of zinc deficiency in the pathomechanisms of selected diseases, JBIC Journal of Biological Inorganic Chemistry, 19, 7, (1069), (2014).
  • , Graphitic carbon nitride solid nanofilms for selective and recyclable sensing of Cu2+ and Ag+ in water and serum, Chem. Commun., 50, 97, (15415), (2014).
  • , Zinc and the aging brain, Genes & Nutrition, 9, 1, (2014).
  • , Toxicology of Metals, Reference Module in Biomedical Sciences, 10.1016/B978-0-12-801238-3.00209-9, (2014).
  • , Gas Chromatography Time-Of-Flight Mass Spectrometry (GC-TOF-MS)-Based Metabolomics for Comparison of Caffeinated and Decaffeinated Coffee and Its Implications for Alzheimer’s Disease, PLoS ONE, 9, 8, (e104621), (2014).
  • , Decreased serum zinc is an effect of ageing and not Alzheimer's disease, Metallomics, 6, 7, (1216), (2014).
  • , Disruption of zinc homeostasis and the pathogenesis of senile dementia, Metallomics, 6, 2, (209), (2014).
  • , Copper subtype of Alzheimer's disease (AD): Meta-analyses, genetic studies and predictive value of non-ceruloplasmim copper in mild cognitive impairment conversion to full AD, Journal of Trace Elements in Medicine and Biology, 28, 4, (482), (2014).
  • , Fluorescent chemosensor based on pyrrole-aminoindanol for selective zinc detection, Inorganic Chemistry Communications, 50, (24), (2014).
  • , An enzyme-free and label-free assay for copper(ii) ion detection based on self-assembled DNA concatamers and Sybr Green I, The Analyst, 138, 17, (4737), (2013).
  • , Nutrition and the Risk of Alzheimer's Disease, BioMed Research International, 10.1155/2013/524820, 2013, (1-12), (2013).
  • , Low levels of copper disrupt brain amyloid-β homeostasis by altering its production and clearance, Proceedings of the National Academy of Sciences, 110, 36, (14771), (2013).
  • , Administering Copper Blocks CA1 Neuron Hyper-Excitability in Rat Hippocampal Slices, Journal of Behavioral and Brain Science, 10.4236/jbbs.2013.35041, 03, 05, (403-408), (2013).
  • , Glyphosate’s Suppression of Cytochrome P450 Enzymes and Amino Acid Biosynthesis by the Gut Microbiome: Pathways to Modern Diseases, Entropy, 15, 12, (1416), (2013).
  • , Metals, oxidative stress and neurodegeneration: A focus on iron, manganese and mercury, Neurochemistry International, 62, 5, (575), (2013).
  • , Potential Prevention and Treatment of Maifanite for Alzheimer's Disease Based on Behavior Test, Oxidative Stress Assay, and Trace Element Analysis in Hippocampus of Aβ(25–35)-Induced AD Rats, Biological Trace Element Research, 152, 1, (50), (2013).
  • , Inhibition of human high-affinity copper importer Ctr1 orthologous in the nervous system of Drosophila ameliorates Aβ42-induced Alzheimer's disease–like symptoms, Neurobiology of Aging, 34, 11, (2604), (2013).
  • , Metals in the causation and treatment of Wilson’s disease and Alzheimer’s disease, and copper lowering therapy in medicine, Inorganica Chimica Acta, 393, (135), (2012).
  • , Copper and Oxidative Stress in the Pathogenesis of Alzheimer’s Disease, Biochemistry, 10.1021/bi3006169, 51, 32, (6289-6311), (2012).
  • , Copper in Brain and Neurodegeneration, Encyclopedia of Inorganic and Bioinorganic Chemistry, (1-21), (2013).
  • , Picomolar Level Detection of Copper(II) and Mercury(II) Ions Using Dual-Stabilizer-Capped CdTe Quantum Dots, Journal of Analysis and Testing, 10.1007/s41664-017-0038-0, (2017).